Stockreport

SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update

Scienture Holdings, Inc.  (SCNX) 
PDF Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K Launched Sales of Arbli™, the First FDA-Approved Ready-To-Use Liquid Formu [Read more]